European Respiratory Society (ERS) 2024

Poster session information:

PS-14: Monitoring in airway disease I: looking towards the future

Poster Session: AI-Based Quality Assessment of Peak Expiratory Flow in Spirometry

Date: Sunday, September 8

Time: 8:00 – 9:30 CET

Authors:

• Benoit Cuyvers – Upstream AI Product Manager at ArtiQ NV, a Clario Company
• Maarten De Vos – R&D Advisor at ArtiQ NV, a Clario Company
• Paul Desbordes – AI Scientist at ArtiQ NV, a Clario Company
• Diana Teixeira E Silva – AI Scientist at ArtiQ NV, a Clario Company
• Marko Topalovic – SVP, Chief AI Officer at ArtiQ NV, a Clario Company

A1 Oral presentation topic: Enhancing respiratory care with technology and improving effectiveness of smoking cessation programme

Oral poster title: Late Breaking Abstract – SPIROmetry interpretation in primary care with or without Artificial Intelligence Decision support software (SPIRO-AID) – led by Prof. William Man, Professor of Respiratory Medicine, Royal Brompton & Harefield Hospitals

Date: Sunday, September 8

Time: 10:15 – 11:45 CET

Authors:

• Karolien Van Orshoven – Lead Project Manager at ArtiQ NV, a Clario Company
• Maarten De Vos – R&D Advisor at ArtiQ NV, a Clario Company
• Ahmed Elmahy – AI Scientist at ArtiQ NV, a Clario Company
• Benoit Cuyvers – Upstream AI Product Manager at ArtiQ NV, a Clario Company
• Paul Desbordes – AI Scientist at ArtiQ NV, a Clario Company
• Marko Topalovic – SVP, Chief AI Officer at ArtiQ NV, a Clario Company

A1 Oral presentation topic: Man and machine: getting the balance right from innovation to implementation

Oral poster title: Identification of COPD from primary care spirometry with artificial intelligence (AI) interpretation software: a retrospective, diagnostic accuracy study – led by Prof. William Man, Professor of Respiratory Medicine, Royal Brompton & Harefield Hospitals

Date: Sunday, September 8

Time: 11:00 – 12:15 CET

Authors:

• Karolien Van Orshoven – Lead Project Manager at ArtiQ NV, a Clario Company
• Maarten De Vos – R&D Advisor at ArtiQ NV, a Clario Company
• Ahmed Elmahy – AI Scientist at ArtiQ NV, a Clario Company
• Benoit Cuyvers – Upstream AI Product Manager at ArtiQ NV, a Clario Company
• Paul Desbordes – AI Scientist at ArtiQ NV, a Clario Company
• Marko Topalovic – SVP, Chief AI Officer at ArtiQ NV, a Clario Company

PS-20: Pulmonary function tests: advanced technology and improved quality control for better patient care

Poster Session: Detection of a common method for undermining the evaluation of full inflation in a clinical trial for asthma

Date: Monday, September 9

Time: 8:00 – 9:30 CET

Authors:

• Kevin McCarthy – Director, Respiratory Science at Clario
• Phil Lake, Ph.D. – Senior Director, Respiratory Solutions at Clario

PS-27: Looking for biomarkers in interstitial lung disease of known origins

Poster Session: Big data insights in the ILD population through AI-driven analytics

Date: Monday, September 9

Time: 8:00 – 9:30 CET

Authors:

• Ahmed Elmahy – AI Scientist at ArtiQ NV, a Clario Company
• Maarten De Vos – R&D Advisor at ArtiQ NV, a Clario Company
• Julie Maes – Upstream AI Product Manager at ArtiQ NV, a Clario Company
• Elena Smets – Upstream AI Product Manager at ArtiQ NV, a Clario Company
• Marko Topalovic – SVP, Chief AI Officer at ArtiQ NV, a Clario Company

PS-14: Monitoring in airway disease II: looking towards the future

Poster Session: AI model generalization assessed on unlabeled pulmonary function data from daily use

Date: Monday, September 9

Time: 12:30 – 14:00 CET

Authors:

• Ahmed Elmahy – AI Scientist at ArtiQ NV, a Clario Company
• Maarten De Vo – R&D Advisor at ArtiQ NV, a Clario Company
• Julie Maes – Upstream AI Product Manager at ArtiQ NV, a Clario Company
• Elena Smets – Upstream AI Product Manager at ArtiQ NV, a Clario Company
• Marko Topalovic – SVP, Chief AI Officer at ArtiQ NV, a Clario Company

PS-14: Monitoring in airway disease II: looking towards the future

Poster Session: Home Spirometry in Clinical Trials: Evaluating Adherence and Quality in Patients with Asthma

Date: Monday, September 9

Time: 12:30 – 14:00 CET

Authors:

• Benoit Cuyvers – Upstream AI Product Manager at ArtiQ NV, a Clario Company
• Paul Desbordes – AI Scientist at ArtiQ NV, a Clario Company
• Karolien Van Orshoven – Lead Project Manager at ArtiQ NV, a Clario Company
• Marko Topalovic – SVP, Chief AI Officer at ArtiQ NV, a Clario Company

PS-3: A primary care approach to chronic obstructive pulmonary disease

Poster Session: A case study on the impact of Artificial Intelligence supported spirometry in primary care

Date: Tuesday, September 10

Time: 8:00 – 9:30 CET

Authors:

• Elena Smets – Upstream AI Product Manager at ArtiQ NV, a Clario Company
• Julie Maes – Upstream AI Product Manager at ArtiQ NV, a Clario Company
• Marko Topalovic – SVP, Chief AI Officer at ArtiQ NV, a Clario Company